HCAR2 Cancer Research Results

HCAR2, HCAR2/GPR109A: Click to Expand ⟱
Source:
Type:
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.


Scientific Papers found: Click to Expand⟱
5733- Buty,  VitB3,    Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
- in-vivo, CRC, NA
GutMicro↑, HCAR2↑, AntiCan↑, Inflam↓, IL18↑,
5732- Buty,    GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon
- Study, CRC, NA
HCAR2↑, other↓, Apoptosis↑, HDAC↓, Bcl-2↓, Bcl-xL↓, cycD1/CCND1↓, DR5↑, NF-kB↓, GutMicro↑, SLC12A5↝,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death

Apoptosis↑, 1,   Bcl-2↓, 1,   Bcl-xL↓, 1,   DR5↑, 1,  

Kinase & Signal Transduction

HCAR2↑, 2,  

Transcription & Epigenetics

other↓, 1,  

Cell Cycle & Senescence

cycD1/CCND1↓, 1,  

Proliferation, Differentiation & Cell State

HDAC↓, 1,  

Barriers & Transport

SLC12A5↝, 1,  

Immune & Inflammatory Signaling

HCAR2↑, 2,   IL18↑, 1,   Inflam↓, 1,   NF-kB↓, 1,  

Clinical Biomarkers

GutMicro↑, 2,  

Functional Outcomes

AntiCan↑, 1,  
Total Targets: 15

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: HCAR2, HCAR2/GPR109A
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:6  Cells:%  prod#:%  Target#:1457  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page